ENTO
Entero Therapeutics
ENTO
ENTO
8 hedge funds and large institutions have $44.9K invested in Entero Therapeutics in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
8
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$16.3K | |
| 2 | +$4.68K | |
| 3 | +$2.36K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$7 |
Top Sellers
| 1 | -$11K | |
| 2 | -$10.3K | |
| 3 | -$3.46K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.51K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$32 |